Convidecia (redirect from CanSino COVID-19 vaccine) COVID-19 that is also used as an inhaled booster. It was developed by CanSino Biologics, with Phase III trials conducted in Argentina, Chile, Mexico, Pakistan... 36 KB (3,379 words) - 00:52, 31 December 2023 |
Sputnik V by the Gamaleya Institute (February 2, 2021) Ad5-nCoV by CanSino Biologics Inc. (February 9, 2021) CoronaVac by Sinovac Research and Development... 10 KB (796 words) - 15:33, 1 January 2024 |
(NASDAQ:ZLAB; HKSE:9688), CanSino Biologics(SSE:688185; HKSE:6185), Caidya, Chain Medical Labs, Belief BioMed, Zencore Biologics, Valgen MedTech, Alamar... 9 KB (828 words) - 03:17, 5 February 2024 |
reached an exclusive deal with CanSino Biologics. However, due to deteriorating Canadian-Chinese relations, the Cansino deal fell through. On August 5... 220 KB (18,134 words) - 11:39, 26 March 2024 |
authorizes use of China's CanSino vaccine against COVID-19". Reuters. 15 June 2021. Retrieved 16 June 2021. "China's CanSino Biologics COVID-19 vaccine receives... 318 KB (19,351 words) - 20:33, 14 March 2024 |
Foreign Affairs of Mexico Marcelo Ebrard announced agreements with CanSino Biologics and Walvax to conduct clinical trials for vaccines from China, with... 36 KB (3,258 words) - 05:56, 10 March 2024 |
October 2022, China began administering an oral vaccine developed by CanSino Biologics using its adenovirus model. Despite the availability of mRNA and viral... 191 KB (21,884 words) - 08:58, 18 March 2024 |
reached an exclusive deal with CanSino Biologics. However, due to deteriorating Canadian-Chinese relations, the Cansino deal fell through. On August 5... 122 KB (13,732 words) - 02:06, 7 February 2024 |
approved the emergency use of the Convidecia vaccine developed by CanSino Biologics. On 24 February 2021, Pakistan announced all coronavirus restrictions... 191 KB (18,700 words) - 15:41, 3 March 2024 |
The Center for Biologics Evaluation and Research (CBER) is one of six main centers for the U.S. Food and Drug Administration (FDA), which is a part of... 13 KB (1,517 words) - 13:17, 22 March 2023 |
of Biological Sciences at the University of Montreal. Starting in June, the Ad5-nCoV vaccine, developed by the Chinese company CanSino Biologics (Tianjin... 180 KB (17,227 words) - 15:36, 6 March 2024 |
Shirō Ishii (category Japanese biological weapons program) application of biological weapons at Unit 731 in Manchukuo during the Second Sino-Japanese War from 1937 to 1945, including the bubonic plague attacks at Chinese... 21 KB (2,306 words) - 23:20, 26 March 2024 |
Unit 731 (category Second Sino-Japanese War crimes) that engaged in lethal human experimentation and biological weapons manufacturing during the Second Sino-Japanese War (1937–1945) and World War II. It killed... 128 KB (14,237 words) - 06:53, 28 March 2024 |
Unit 543 (category Second Sino-Japanese War crimes) Japanese military police. Japanese war crimes List of Japanese War Atrocities Kantogun Second Sino-Japanese War Hal Gold, Unit 731 Testimony, 2003 v t e... 932 bytes (55 words) - 08:30, 20 January 2024 |
Unit Ei 1644 (category Second Sino-Japanese War) It had 12 branches and employed about 1,500 men.: 307 During the Second Sino-Japanese War, Unit Ei engaged in "producing on a mass scale lethal bacteria... 9 KB (1,055 words) - 22:47, 13 January 2024 |